Imageens
Imageens is a DeepTech company founded in 2017 that develops clinically validated medical image processing software focused on cardiovascular health. Their flagship product, ArtFun+, is a CE class 2a medical device software that measures advanced cardiovascular MRI imaging biomarkers such as arterial stiffness, which are major predictors of cardiovascular disease and mortality. Imageens leverages AI and proprietary data to provide predictive clinical decision tools for cardiovascular risk and aging, supporting cardiologists and clinics in preventive cardiovascular medicine. The company collaborates with leading healthcare institutions and has contributed to over 77 publications, with extensive clinical validation involving 3,675 patients and 1.5 million images. Imageens holds prestigious innovation awards and labels, positioning itself as a leader in AI-driven cardiovascular imaging and predictive medicine in Europe.
Imageens
Imageens is a DeepTech company founded in 2017 that develops clinically validated medical image processing software focused on cardiovascular health. Their flagship product, ArtFun+, is a CE class 2a medical device software that measures advanced cardiovascular MRI imaging biomarkers such as arterial stiffness, which are major predictors of cardiovascular disease and mortality. Imageens leverages AI and proprietary data to provide predictive clinical decision tools for cardiovascular risk and aging, supporting cardiologists and clinics in preventive cardiovascular medicine. The company collaborates with leading healthcare institutions and has contributed to over 77 publications, with extensive clinical validation involving 3,675 patients and 1.5 million images. Imageens holds prestigious innovation awards and labels, positioning itself as a leader in AI-driven cardiovascular imaging and predictive medicine in Europe.